Sign inJoin waitlistJoin the waitlist

MD

Maria Delioukina

Hematology & Oncology

Credentials: ·

History

Hematology and Medical Oncology
Internal Medicine

Research

Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised,…
The Lancet Oncology · 2021 · 328 citations
Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphoma
Journal of Clinical Oncology · 2011 · 166 citations
Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non-germinal center B-cell-like DLBCL
Blood · 2019 · 115 citations

Stephen Forman
10 papers
AN
Auayporn Nademanee
5 papers
Leslie Popplewell
5 papers
Jasmine Zain
4 papers
Karl Gaal
3 papers
NK
Neil Kogut
3 papers
Ajai Chari
2 papers
Lee Rosen
2 papers
MK
Mark Kirschbaum
2 papers
RC
Robert Chen
2 papers
Saad Usmani
2 papers
Victoria Bedell
2 papers